The advisory committee’s vote in favor of boosters came just hours after the FDA authorized the shots.
An advisory panel to the Centers for Disease Control and Prevention voted on Friday to recommend Pfizer-BioNTech and Moderna’s COVID-19 booster shots to all adults, a move that simplifies who is eligible for an additional dose.
Friday’s unanimous vote by the Advisory Committee on Immunization Practices strips away the complicated and confusing criteria that had surrounded boosters, with eligibility limited to certain groups and, initially, certain vaccines
